Background and Objectives: Inconsistencies in nasal nitric oxide (nNO) values, due to anatomical variations and comorbidities, challenge the accurate assessment of upper airway inflammation severity. We hypothesized that changes in nNO levels following treatment for chronic rhinitis would be consistent and provide relative value. This study aimed to evaluate the correlation between changes in nNO levels and symptomatic improvements following treatment for chronic rhinitis. Methods: This prospective observational study included 46 participants diagnosed with chronic rhinitis between December 2021 and November 2023. nNO measurements, evaluations of four nasal and two ocular symptoms, and quality of life questionnaires were conducted at baseline and after one month of treatment. Baseline laboratory tests included serum total immunoglobulin E levels, blood eosinophil percentages, and skin prick tests. Results: The Total Nasal Symptom Score (TNSS), TNSS with ocular symptoms (TNSS eye), and Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) scores significantly decreased following treatment (all p<0.001). nNO levels also decreased significantly after treatment (p=0.036). Moreover, changes in nNO were significantly correlated with changes in TNSS, TNSS eye, and RQLQ scores (p=0.047, r=0.294; p=0.021, r=0.340; and p=0.004, r=0.419, respectively). Conclusion In patients with chronic rhinitis, changes in TNSS, TNSS eye, and RQLQ scores were correlated with changes in nNO levels after treatment. nNO may serve as a potential objective evaluation tool for chronic rhinitis, particularly in patients who have difficulty reporting symptoms.

Background and Objectives: Inconsistencies in nasal nitric oxide (nNO) values, due to anatomical variations and comorbidities, challenge the accurate assessment of upper airway inflammation severity. We hypothesized that changes in nNO levels following treatment for chronic rhinitis would be consistent and provide relative value. This study aimed to evaluate the correlation between changes in nNO levels and symptomatic improvements following treatment for chronic rhinitis. Methods: This prospective observational study included 46 participants diagnosed with chronic rhinitis between December 2021 and November 2023. nNO measurements, evaluations of four nasal and two ocular symptoms, and quality of life questionnaires were conducted at baseline and after one month of treatment. Baseline laboratory tests included serum total immunoglobulin E levels, blood eosinophil percentages, and skin prick tests. Results: The Total Nasal Symptom Score (TNSS), TNSS with ocular symptoms (TNSS eye), and Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) scores significantly decreased following treatment (all p<0.001). nNO levels also decreased significantly after treatment (p=0.036). Moreover, changes in nNO were significantly correlated with changes in TNSS, TNSS eye, and RQLQ scores (p=0.047, r=0.294; p=0.021, r=0.340; and p=0.004, r=0.419, respectively). Conclusion In patients with chronic rhinitis, changes in TNSS, TNSS eye, and RQLQ scores were correlated with changes in nNO levels after treatment. nNO may serve as a potential objective evaluation tool for chronic rhinitis, particularly in patients who have difficulty reporting symptoms.

Background and Objectives: Inconsistencies in nasal nitric oxide (nNO) values, due to anatomical variations and comorbidities, challenge the accurate assessment of upper airway inflammation severity. We hypothesized that changes in nNO levels following treatment for chronic rhinitis would be consistent and provide relative value. This study aimed to evaluate the correlation between changes in nNO levels and symptomatic improvements following treatment for chronic rhinitis. Methods: This prospective observational study included 46 participants diagnosed with chronic rhinitis between December 2021 and November 2023. nNO measurements, evaluations of four nasal and two ocular symptoms, and quality of life questionnaires were conducted at baseline and after one month of treatment. Baseline laboratory tests included serum total immunoglobulin E levels, blood eosinophil percentages, and skin prick tests. Results: The Total Nasal Symptom Score (TNSS), TNSS with ocular symptoms (TNSS eye), and Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) scores significantly decreased following treatment (all p<0.001). nNO levels also decreased significantly after treatment (p=0.036). Moreover, changes in nNO were significantly correlated with changes in TNSS, TNSS eye, and RQLQ scores (p=0.047, r=0.294; p=0.021, r=0.340; and p=0.004, r=0.419, respectively). Conclusion In patients with chronic rhinitis, changes in TNSS, TNSS eye, and RQLQ scores were correlated with changes in nNO levels after treatment. nNO may serve as a potential objective evaluation tool for chronic rhinitis, particularly in patients who have difficulty reporting symptoms.

Background: Employees with depression have complex and serious health consequences, not only for them, including reduced quality of life, but also for businesses and society, leading to social costs such as reduced productivity. This study investigated the prevalence of depressive symptoms and related factors among public enterprise employees in Naju Innovation City, Korea. Methods: We investigated the sociodemographic and psychosocial characteristics of 1,061 public enterprise employees. Depression, anxiety, and occupational burnout were assessed using the Patient Health Questionnaire-9, Generalized Anxiety Disorder-7, and Maslach Burnout Inventory-General Survey, respectively. Furthermore, the impact of factors on depressive symptoms was examined using a logistic regression model. Results: The prevalence of overall depressive symptoms was 11.9%. High anxiety (odds ratio [OR]=12.19; 95% confidence interval [CI]=7.17-20.76; p<0.001) and exhaustion (OR=2.79; 95% CI=1.81-4.40; p<0.001) levels were significantly associated with depressive symptoms. Conclusion Anxiety symptoms and exhaustion were the most important factors related to depressive symptoms among the public enterprise employees. Hence, when providing an employee assistance program, the psychosocial vulnerability factors of workers with depressive symptoms should be thoroughly addressed.2

Background: Employees with depression have complex and serious health consequences, not only for them, including reduced quality of life, but also for businesses and society, leading to social costs such as reduced productivity. This study investigated the prevalence of depressive symptoms and related factors among public enterprise employees in Naju Innovation City, Korea. Methods: We investigated the sociodemographic and psychosocial characteristics of 1,061 public enterprise employees. Depression, anxiety, and occupational burnout were assessed using the Patient Health Questionnaire-9, Generalized Anxiety Disorder-7, and Maslach Burnout Inventory-General Survey, respectively. Furthermore, the impact of factors on depressive symptoms was examined using a logistic regression model. Results: The prevalence of overall depressive symptoms was 11.9%. High anxiety (odds ratio [OR]=12.19; 95% confidence interval [CI]=7.17-20.76; p<0.001) and exhaustion (OR=2.79; 95% CI=1.81-4.40; p<0.001) levels were significantly associated with depressive symptoms. Conclusion Anxiety symptoms and exhaustion were the most important factors related to depressive symptoms among the public enterprise employees. Hence, when providing an employee assistance program, the psychosocial vulnerability factors of workers with depressive symptoms should be thoroughly addressed.2

Background: Employees with depression have complex and serious health consequences, not only for them, including reduced quality of life, but also for businesses and society, leading to social costs such as reduced productivity. This study investigated the prevalence of depressive symptoms and related factors among public enterprise employees in Naju Innovation City, Korea. Methods: We investigated the sociodemographic and psychosocial characteristics of 1,061 public enterprise employees. Depression, anxiety, and occupational burnout were assessed using the Patient Health Questionnaire-9, Generalized Anxiety Disorder-7, and Maslach Burnout Inventory-General Survey, respectively. Furthermore, the impact of factors on depressive symptoms was examined using a logistic regression model. Results: The prevalence of overall depressive symptoms was 11.9%. High anxiety (odds ratio [OR]=12.19; 95% confidence interval [CI]=7.17-20.76; p<0.001) and exhaustion (OR=2.79; 95% CI=1.81-4.40; p<0.001) levels were significantly associated with depressive symptoms. Conclusion Anxiety symptoms and exhaustion were the most important factors related to depressive symptoms among the public enterprise employees. Hence, when providing an employee assistance program, the psychosocial vulnerability factors of workers with depressive symptoms should be thoroughly addressed.2

Background: Employees with depression have complex and serious health consequences, not only for them, including reduced quality of life, but also for businesses and society, leading to social costs such as reduced productivity. This study investigated the prevalence of depressive symptoms and related factors among public enterprise employees in Naju Innovation City, Korea. Methods: We investigated the sociodemographic and psychosocial characteristics of 1,061 public enterprise employees. Depression, anxiety, and occupational burnout were assessed using the Patient Health Questionnaire-9, Generalized Anxiety Disorder-7, and Maslach Burnout Inventory-General Survey, respectively. Furthermore, the impact of factors on depressive symptoms was examined using a logistic regression model. Results: The prevalence of overall depressive symptoms was 11.9%. High anxiety (odds ratio [OR]=12.19; 95% confidence interval [CI]=7.17-20.76; p<0.001) and exhaustion (OR=2.79; 95% CI=1.81-4.40; p<0.001) levels were significantly associated with depressive symptoms. Conclusion Anxiety symptoms and exhaustion were the most important factors related to depressive symptoms among the public enterprise employees. Hence, when providing an employee assistance program, the psychosocial vulnerability factors of workers with depressive symptoms should be thoroughly addressed.2

Background: Employees with depression have complex and serious health consequences, not only for them, including reduced quality of life, but also for businesses and society, leading to social costs such as reduced productivity. This study investigated the prevalence of depressive symptoms and related factors among public enterprise employees in Naju Innovation City, Korea. Methods: We investigated the sociodemographic and psychosocial characteristics of 1,061 public enterprise employees. Depression, anxiety, and occupational burnout were assessed using the Patient Health Questionnaire-9, Generalized Anxiety Disorder-7, and Maslach Burnout Inventory-General Survey, respectively. Furthermore, the impact of factors on depressive symptoms was examined using a logistic regression model. Results: The prevalence of overall depressive symptoms was 11.9%. High anxiety (odds ratio [OR]=12.19; 95% confidence interval [CI]=7.17-20.76; p<0.001) and exhaustion (OR=2.79; 95% CI=1.81-4.40; p<0.001) levels were significantly associated with depressive symptoms. Conclusion Anxiety symptoms and exhaustion were the most important factors related to depressive symptoms among the public enterprise employees. Hence, when providing an employee assistance program, the psychosocial vulnerability factors of workers with depressive symptoms should be thoroughly addressed.2

In patients with unstable mandibular movements who are accompanied by involuntary facial muscle movements and asymmetrical changes in the facial features, many difficulties exist in determining the vertical dimension of occlusion, recording centric relation, and transferring information about the occlusal plane. In this case, for a patient with unilateral facial nerve palsy who was edentulous for a long period of time, a CAD-CAM provisional prosthesis was fabricated using a 3D printing customized gothic arch tracer and a prefabricated occlusal plane recorder, the POP bow system, to achieve a stable interarch relationship. Afterwards, a full mouth implant fixed prosthesis was fabricated by delivering an appropriate vertical dimension of occlusion, a reproducible centric relation, and a correct three-dimensional occlusal plane, and continuous maintenance was performed to restore functional and aesthetic oral health to the patient.

The survival rate of children admitted in the neonatal intensive care unit (NICU) after birth is on the increase; hence, proper evaluation and care of their neurodevelopment has become an important issue. Neurodevelopmental assessments of individual domains regarding motor, language, cognition, and sensory perception are crucial in planning prompt interventions for neonates requiring immediate support and rehabilitation treatment. These assessments are essential for identifying areas of weakness and designing targeted interventions to improve future functional outcomes and the quality of lives for both the infants and their families. However, initial stratification of risk to select those who are in danger of neurodevelopmental disorders is also important in terms of cost-effectiveness. Efficient and robust functional evaluations to recognize early signs of developmental disorders will help NICU graduates receive interventions and enhance functional capabilities if needed. Several age-dependent, domain-specific neurodevelopmental assessment tools are available; therefore, this review summarizes the characteristics of these tools and aims to develop multidimensional, standardized, and regular follow-up plans for NICU graduates in Korea.